PPD, Inc. (PPDI) Adds New Central Laboratory Services to Meet Growing Client Needs
2/7/2013 10:00:36 AM
WILMINGTON, N.C.--(BUSINESS WIRE)--Pharmaceutical Product Development, LLC (PPD) today announced it has strengthened its central laboratory testing services in infectious diseases, one of the largest therapeutic areas for clinical research and development. PPD has expanded its testing capabilities at its Brussels and Singapore labs, offering clients additional microbiology, peripheral blood mononuclear cell and molecular pathology services. Like its Highland Heights, Ky., facility, PPD’s labs in Brussels and Singapore now offer a full range of microbiology testing services for bacteriology, mycology, parasitology and microbioterrorism pathogens. All three labs can conduct extensive virology testing, including real-time polymerase chain reaction, viral load, genotyping and SNP analysis. The laboratories also have the capability to culture, quantitate, identify and determine antibiotic susceptibility and resistance for aerobic and anaerobic organisms.
comments powered by